Healthcare

Life Healthcare runs private hospitals and related healthcare services, with a strong Southern African base and meaningful cash generation. The key attraction is a solid healthcare asset base trading at a restrained valuation while management works to simplify the group.

LB Pharmaceuticals is a clinical-stage biotech focused on psychiatric disorders, with value tied to pipeline progress rather than current sales. A low-debt balance sheet and strong recent share momentum make its upcoming development milestones especially important to watch.

Iradimed makes MRI-compatible infusion and monitoring systems for hospitals, serving a specialized need that supports high margins, strong returns, and a very clean balance sheet. The main debate is not business quality, but how much future growth is already reflected in the stock.

InnovAge provides all-inclusive care for older adults through the PACE model, a niche with strong demographic support. Recent revenue growth, better cash generation, and a return to operating profit make the company’s turnaround increasingly worth a closer look.

Integra LifeSciences sells specialized surgical and tissue repair products used in hospitals, with notable positions in neurosurgery and regenerative technologies. The business serves durable clinical needs, and the key question is how much value a future operational recovery could unlock.

Harrow Health is building a focused ophthalmic drug platform with fast revenue growth, rising gross profit, and improving cash generation. Its appeal rests on the chance to turn a specialized eye-care portfolio into a more scalable and financially durable business.

GoodRx helps consumers find lower prescription prices through a well-known digital platform and has recently improved profitability and cash generation. Its appeal now rests on whether a stronger operating profile can be matched by steadier growth across its core marketplace.